Gandhi, K.; Barzegar-Fallah, A.; Banstola, A.; Rizwan, S.B.; Reynolds, J.N.J.
Ultrasound-Mediated Blood–Brain Barrier Disruption for Drug Delivery: A Systematic Review of Protocols, Efficacy, and Safety Outcomes from Preclinical and Clinical Studies. Pharmaceutics 2022, 14, 833.
https://doi.org/10.3390/pharmaceutics14040833
AMA Style
Gandhi K, Barzegar-Fallah A, Banstola A, Rizwan SB, Reynolds JNJ.
Ultrasound-Mediated Blood–Brain Barrier Disruption for Drug Delivery: A Systematic Review of Protocols, Efficacy, and Safety Outcomes from Preclinical and Clinical Studies. Pharmaceutics. 2022; 14(4):833.
https://doi.org/10.3390/pharmaceutics14040833
Chicago/Turabian Style
Gandhi, Kushan, Anita Barzegar-Fallah, Ashik Banstola, Shakila B. Rizwan, and John N. J. Reynolds.
2022. "Ultrasound-Mediated Blood–Brain Barrier Disruption for Drug Delivery: A Systematic Review of Protocols, Efficacy, and Safety Outcomes from Preclinical and Clinical Studies" Pharmaceutics 14, no. 4: 833.
https://doi.org/10.3390/pharmaceutics14040833
APA Style
Gandhi, K., Barzegar-Fallah, A., Banstola, A., Rizwan, S. B., & Reynolds, J. N. J.
(2022). Ultrasound-Mediated Blood–Brain Barrier Disruption for Drug Delivery: A Systematic Review of Protocols, Efficacy, and Safety Outcomes from Preclinical and Clinical Studies. Pharmaceutics, 14(4), 833.
https://doi.org/10.3390/pharmaceutics14040833